Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,613,601
-$18,486,747 QoQ
Shares Held
227,910
-90.9% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 164 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in GRFS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,613,601 | 227,910 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $20,100,348 | 2,506,278 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $41,090,911 | 4,394,750 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $30,016,680 | 3,013,723 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $824,293 | 91,183 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $609,966 | 85,790 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $527,167 | 70,856 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $682,826 | 76,895 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $445,737 | 70,640 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $419,863 | 62,854 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $775,339 | 67,071 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $578,680 | 63,313 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $576,868 | 62,977 | Shares | Defined | 2023-08-02 | |
| 2022-06-30 | $1,367,873 | 115,141 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,373,204 | 117,569 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,933,659 | 172,187 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,127,949 | 77,204 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,154,312 | 66,531 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $46,665 | 2,699 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $59,948 | 3,251 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $47,192 | 2,720 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $43,994 | 2,412 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $43,663 | 2,168 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||